105 related articles for article (PubMed ID: 9373173)
1. Suramin enters and accumulates in low pH intracellular compartments of v-sis-transformed NIH 3T3 cells.
Huang SS; Koh HA; Huang JS
FEBS Lett; 1997 Oct; 416(3):297-301. PubMed ID: 9373173
[TBL] [Abstract][Full Text] [Related]
2. Cell surface retention sequence binding protein-1 interacts with the v-sis gene product and platelet-derived growth factor beta-type receptor in simian sarcoma virus-transformed cells.
Boensch C; Huang SS; Connolly DT; Huang JS
J Biol Chem; 1999 Apr; 274(15):10582-9. PubMed ID: 10187853
[TBL] [Abstract][Full Text] [Related]
3. The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex.
Hart KC; Xu YF; Meyer AN; Lee BA; Donoghue DJ
J Cell Biol; 1994 Dec; 127(6 Pt 2):1843-57. PubMed ID: 7806564
[TBL] [Abstract][Full Text] [Related]
4. Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation.
Huang SS; Huang JS
J Biol Chem; 1988 Sep; 263(25):12608-18. PubMed ID: 2842336
[TBL] [Abstract][Full Text] [Related]
5. Intracellular retention of membrane-anchored v-sis protein abrogates autocrine signal transduction.
Lee BA; Donoghue DJ
J Cell Biol; 1992 Sep; 118(5):1057-70. PubMed ID: 1324943
[TBL] [Abstract][Full Text] [Related]
6. Intracellular turnover, novel secretion, and mitogenically active intracellular forms of v-sis gene product in simian sarcoma virus-transformed cells. Implications for intracellular loop autocrine transformation.
Lokeshwar VB; Huang SS; Huang JS
J Biol Chem; 1990 Jan; 265(3):1665-75. PubMed ID: 2153139
[TBL] [Abstract][Full Text] [Related]
7. The v-sis protein retains biological activity as a type II membrane protein when anchored by various signal-anchor domains, including the hydrophobic domain of the bovine papilloma virus E5 oncoprotein.
Xu YF; Meyer AN; Webster MK; Lee BA; Donoghue DJ
J Cell Biol; 1993 Nov; 123(3):549-60. PubMed ID: 8227125
[TBL] [Abstract][Full Text] [Related]
8. Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors.
Fleming TP; Matsui T; Molloy CJ; Robbins KC; Aaronson SA
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8063-7. PubMed ID: 2813378
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor (PDGF) receptor activation in cell transformation and human malignancy.
Fleming TP; Matsui T; Aaronson SA
Exp Gerontol; 1992; 27(5-6):523-32. PubMed ID: 1385192
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Regenass U; Lydon NB
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2558-62. PubMed ID: 7708684
[TBL] [Abstract][Full Text] [Related]
11. The v-sis oncogene product but not platelet-derived growth factor (PDGF) A homodimers activate PDGF alpha and beta receptors intracellularly and initiate cellular transformation.
Bejcek BE; Hoffman RM; Lipps D; Li DY; Mitchell CA; Majerus PW; Deuel TF
J Biol Chem; 1992 Feb; 267(5):3289-93. PubMed ID: 1310684
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of heparin on normal and transformed NIH/3T3 fibroblasts.
Cavari S; Ruggiero M; Vannucchi S
Cell Biol Int; 1993 Aug; 17(8):781-6. PubMed ID: 8106075
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor (PDGF) B and A homodimers transform murine fibroblasts depending on the genetic background of the cell.
Kim HR; Upadhyay S; Korsmeyer S; Deuel TF
J Biol Chem; 1994 Dec; 269(48):30604-8. PubMed ID: 7982979
[TBL] [Abstract][Full Text] [Related]
14. Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors.
Garrett JS; Coughlin SR; Niman HL; Tremble PM; Giels GM; Williams LT
Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7466-70. PubMed ID: 6095298
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
16. Autocrine stimulation by the v-sis gene product requires a ligand-receptor interaction at the cell surface.
Hannink M; Donoghue DJ
J Cell Biol; 1988 Jul; 107(1):287-98. PubMed ID: 2455725
[TBL] [Abstract][Full Text] [Related]
17. NIH 3T3 cells transfected with a yeast H(+)-ATPase have altered sensitivity to insulin, insulin growth factor-I, and platelet-derived growth factor-AA.
Peterson EP; Martinez GM; Martinez-Zaguilan R; Perona R; Gillies RJ
J Cell Physiol; 1994 Jun; 159(3):551-60. PubMed ID: 8188769
[TBL] [Abstract][Full Text] [Related]
18. Transformation-specific pattern of phosphorylation of c-Jun, Jun-B, Jun-D and Egr-1 in v-sis transformed cells.
Grover-Bardwick A; Adamson E; Mercola D
Carcinogenesis; 1994 Aug; 15(8):1667-74. PubMed ID: 8055649
[TBL] [Abstract][Full Text] [Related]
19. Membrane-anchored form of v-sis/PDGF-B induces mitogenesis without detectable PDGF receptor autophosphorylation.
Lee BA; Donoghue DJ
J Cell Biol; 1991 Apr; 113(2):361-70. PubMed ID: 1849139
[TBL] [Abstract][Full Text] [Related]
20. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).
Ahn HY; Hadizadeh KR; Seul C; Yun YP; Vetter H; Sachinidis A
Mol Biol Cell; 1999 Apr; 10(4):1093-104. PubMed ID: 10198059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]